Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.
- van Ingen, J.
- Aliberti, S.
- Andrejak, C.
- Chalmers, J. D.
- Codecasa, L. R.
- Daley, C. L.
- Hasegawa, N.
- Griffith, D. E.
- Hoefsloot, W.
- Huitt, G.
- Jarand, J.
- Jhun, B. W.
- Loebinger, M. R.
- Marras, T. K.
- Morimoto, K.
- Polverino, E.
- Ringshausen, F. C.
- Santin, M.
- Thomson, R.
- Wagner, D.
- Wallace, R. J.
- Winthrop, K. L.
- Yim, J. J.
Keywords
- *Drug-Related Side Effects and Adverse Reactions
- Humans
- *Lung Diseases/chemically induced
- *Mycobacterium Infections, Nontuberculous
- Mycobacterium avium Complex
- *Mycobacterium avium-intracellulare Infection/drug therapy
- Nontuberculous Mycobacteria
- *Mycobacterium avium complex
- *adverse events
- *antibiotic treatment
- *azithromycin
- *nontuberculous mycobacteria